256 related articles for article (PubMed ID: 1398068)
1. Site-specific binding of wild-type p53 to cellular DNA is inhibited by SV40 T antigen and mutant p53.
Bargonetti J; Reynisdóttir I; Friedman PN; Prives C
Genes Dev; 1992 Oct; 6(10):1886-98. PubMed ID: 1398068
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylation studies on rat p53 using the baculovirus expression system. Manipulation of the phosphorylation state with okadaic acid and influence on DNA binding.
Fuchs B; Hecker D; Scheidtmann KH
Eur J Biochem; 1995 Mar; 228(3):625-39. PubMed ID: 7737156
[TBL] [Abstract][Full Text] [Related]
3. Abrogation of p53-mediated transactivation by SV40 large T antigen.
Segawa K; Minowa A; Sugasawa K; Takano T; Hanaoka F
Oncogene; 1993 Mar; 8(3):543-8. PubMed ID: 8382354
[TBL] [Abstract][Full Text] [Related]
4. Purification and characterization of a protein kinase which is activated by SV40 large T-antigen and phosphorylates the tumor suppressor protein p53.
Müller E; Scheidtmann KH
Oncogene; 1995 Mar; 10(6):1175-85. PubMed ID: 7700642
[TBL] [Abstract][Full Text] [Related]
5. Wild-type, but not mutant, human p53 proteins inhibit the replication activities of simian virus 40 large tumor antigen.
Friedman PN; Kern SE; Vogelstein B; Prives C
Proc Natl Acad Sci U S A; 1990 Dec; 87(23):9275-9. PubMed ID: 2174557
[TBL] [Abstract][Full Text] [Related]
6. SV40 T antigen abrogates p53-mediated transcriptional activity.
Jiang D; Srinivasan A; Lozano G; Robbins PD
Oncogene; 1993 Oct; 8(10):2805-12. PubMed ID: 8378089
[TBL] [Abstract][Full Text] [Related]
7. pZ402, an improved SV40-based shuttle vector containing a T-antigen mutant unable to interact with wild-type p53.
Kraus E; Strong LC; Tainsky MA
Gene; 1998 May; 211(2):229-34. PubMed ID: 9602136
[TBL] [Abstract][Full Text] [Related]
8. The transcriptional transactivation function of wild-type p53 is inhibited by SV40 large T-antigen and by HPV-16 E6 oncoprotein.
Mietz JA; Unger T; Huibregtse JM; Howley PM
EMBO J; 1992 Dec; 11(13):5013-20. PubMed ID: 1464323
[TBL] [Abstract][Full Text] [Related]
9. Cooperation of simian virus 40 large and small T antigens in metabolic stabilization of tumor suppressor p53 during cellular transformation.
Tiemann F; Zerrahn J; Deppert W
J Virol; 1995 Oct; 69(10):6115-21. PubMed ID: 7666515
[TBL] [Abstract][Full Text] [Related]
10. Tissue-specific expression of SV40 in tumors associated with the Li-Fraumeni syndrome.
Malkin D; Chilton-MacNeill S; Meister LA; Sexsmith E; Diller L; Garcea RL
Oncogene; 2001 Jul; 20(33):4441-9. PubMed ID: 11494139
[TBL] [Abstract][Full Text] [Related]
11. The ability of simian virus 40 large T antigen to immortalize primary mouse embryo fibroblasts cosegregates with its ability to bind to p53.
Zhu JY; Abate M; Rice PW; Cole CN
J Virol; 1991 Dec; 65(12):6872-80. PubMed ID: 1658380
[TBL] [Abstract][Full Text] [Related]
12. The requirement of the carboxyl terminus of p53 for DNA binding and transcriptional activation depends on the specific p53 binding DNA element.
Zhang W; Guo XY; Deisseroth AB
Oncogene; 1994 Sep; 9(9):2513-21. PubMed ID: 8058314
[TBL] [Abstract][Full Text] [Related]
13. Wild-type but not mutant p53 immunopurified proteins bind to sequences adjacent to the SV40 origin of replication.
Bargonetti J; Friedman PN; Kern SE; Vogelstein B; Prives C
Cell; 1991 Jun; 65(6):1083-91. PubMed ID: 1646078
[TBL] [Abstract][Full Text] [Related]
14. Several mutant p53 proteins detected in cancer-prone families with Li-Fraumeni syndrome exhibit transdominant effects on the biochemical properties of the wild-type p53.
Srivastava S; Wang S; Tong YA; Pirollo K; Chang EH
Oncogene; 1993 Sep; 8(9):2449-56. PubMed ID: 8361758
[TBL] [Abstract][Full Text] [Related]
15. p53 inhibits DNA replication in vitro in a DNA-binding-dependent manner.
Miller SD; Farmer G; Prives C
Mol Cell Biol; 1995 Dec; 15(12):6554-60. PubMed ID: 8524220
[TBL] [Abstract][Full Text] [Related]
16. Transactivational and DNA binding abilities of endogenous p53 in p53 mutant cell lines.
Park DJ; Nakamura H; Chumakov AM; Said JW; Miller CW; Chen DL; Koeffler HP
Oncogene; 1994 Jul; 9(7):1899-906. PubMed ID: 8208536
[TBL] [Abstract][Full Text] [Related]
17. A proteolytic fragment from the central region of p53 has marked sequence-specific DNA-binding activity when generated from wild-type but not from oncogenic mutant p53 protein.
Bargonetti J; Manfredi JJ; Chen X; Marshak DR; Prives C
Genes Dev; 1993 Dec; 7(12B):2565-74. PubMed ID: 8276239
[TBL] [Abstract][Full Text] [Related]
18. Wild-type p53 mediates positive regulation of gene expression through a specific DNA sequence element.
Zambetti GP; Bargonetti J; Walker K; Prives C; Levine AJ
Genes Dev; 1992 Jul; 6(7):1143-52. PubMed ID: 1628822
[TBL] [Abstract][Full Text] [Related]
19. Mutant p53 proteins behave in a dominant, negative fashion in vivo.
Hachiya M; Chumakov A; Miller CW; Akashi M; Said J; Koeffler HP
Anticancer Res; 1994; 14(5A):1853-9. PubMed ID: 7847818
[TBL] [Abstract][Full Text] [Related]
20. Analysis of p53 transactivation through high-affinity binding sites.
Chumakov AM; Miller CW; Chen DL; Koeffler HP
Oncogene; 1993 Nov; 8(11):3005-11. PubMed ID: 8414502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
